Tilray Brands (TLRY) EPS (Weighted Average and Diluted) (QoQ) (2020 - 2026)
Tilray Brands (TLRY) EPS (Weighted Average and Diluted) (QoQ) (2020 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Teva Pharmaceutical Industries | 39.72 Bn | 35.98 Bn | 1.97 Bn |
| 2 | Zoetis | 34.61 Bn | 32.67 Bn | 1.62 Bn |
| 3 | United Therapeutics | 24.07 Bn | 21.91 Bn | 648.10 Mn |
| 4 | Aurora Cannabis | 16.98 Bn | 16.91 Bn | 33.43 Mn |
| 5 | Neurocrine Biosciences | 16.64 Bn | 15.32 Bn | 800.70 Mn |
| 6 | Elanco Animal Health | 12.19 Bn | 11.76 Bn | 785.00 Mn |
| 7 | Alkermes | 7.37 Bn | 6.86 Bn | -116.06 Mn |
| 8 | Hims & Hers Health | 6.62 Bn | 5.87 Bn | 396.79 Mn |
| 9 | Lantheus Holdings | 6.47 Bn | 5.97 Bn | 230.92 Mn |
| 10 | Tilray Brands | - | - | 54.95 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Feb 28, 2026 | 41.46% |
| Nov 30, 2025 | -28,831.76% |
| Aug 31, 2025 | -99.98% |
| May 31, 2025 | 193.90% |
| Feb 28, 2025 | -777.78% |
| Nov 30, 2024 | -2,375.00% |
| Aug 31, 2024 | 0.00% |
| May 31, 2024 | 66.67% |
| Feb 29, 2024 | -71.43% |
| Nov 30, 2023 | 30.00% |
| Aug 31, 2023 | 33.33% |
| May 31, 2023 | 92.11% |
| Feb 28, 2023 | -1,627.27% |
| Nov 30, 2022 | 15.38% |
| Aug 31, 2022 | 86.87% |
| May 31, 2022 | -1,200.00% |
| Feb 28, 2022 | 614.56% |
| Nov 30, 2021 | 115.74% |
| Aug 31, 2021 | -144.44% |
| May 31, 2021 | 117.48% |